Anti-Pd1 Monoclonal Antibody Syngeneic Mouse
Lab Reagents
Human IgG antibody Laboratories manufactures the anti-pd1 monoclonal antibody syngeneic mouse reagents distributed by Genprice. The Anti-Pd1 Monoclonal Antibody Syngeneic Mouse reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact mouse monoclonal. Other Anti-Pd1 products are available in stock. Specificity: Anti-Pd1 Category: Monoclonal Group: Antibody Syngeneic
Antibody Syngeneic information
PD1 Blocking Antibody |
|||
48361-50ul | SAB | 50ul | EUR 239 |
PD1 Conjugated Antibody |
|||
C48754 | SAB | 100ul | EUR 397 |
PD1 Conjugated Antibody |
|||
C45030 | SAB | 100ul | EUR 397 |
PD1 antibody (FITC) |
|||
61R-1186 | Fitzgerald | 100 ug | EUR 349 |
Description: Rat monoclonal PD1 antibody (FITC) |
PD1 antibody (FITC) |
|||
61R-1189 | Fitzgerald | 100 ug | EUR 349 |
Description: Armenian Hamster monoclonal PD1 antibody (FITC) |
PD1 antibody (PE) |
|||
61R-1443 | Fitzgerald | 100 ug | EUR 386 |
Description: Rat monoclonal PD1 antibody (PE) |
PD1 antibody (PE) |
|||
61R-1444 | Fitzgerald | 100 ug | EUR 386 |
Description: Armenian Hamster monoclonal PD1 antibody (PE) |
PD1 antibody (biotin) |
|||
61R-1692 | Fitzgerald | 100 ug | EUR 300 |
Description: Rat monoclonal PD1 antibody (biotin) |
PD1 antibody (biotin) |
|||
61R-1694 | Fitzgerald | 100 ug | EUR 300 |
Description: Armenian Hamster monoclonal PD1 antibody (biotin) |
PD1 Antibody [4D6] |
|||
RF16001-002mg | ProSci | 0.02 mg | EUR 191.42 |
Description: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD-1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. PD-1 is thus one of a growing number of immune checkpoint proteins. |
PD1 Antibody [4D6] |
|||
RF16001-01mg | ProSci | 0.1 mg | EUR 495.22 |
Description: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD-1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. PD-1 is thus one of a growing number of immune checkpoint proteins. |
PD1 Antibody [8A4] |
|||
RF16002-002mg | ProSci | 0.02 mg | EUR 191.42 |
Description: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD-1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. PD-1 is thus one of a growing number of immune checkpoint proteins. |
PD1 Antibody [8A4] |
|||
RF16002-01mg | ProSci | 0.1 mg | EUR 495.22 |
Description: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD-1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. PD-1 is thus one of a growing number of immune checkpoint proteins. |
PD1 Antibody [7H6] |
|||
RF16003-002mg | ProSci | 0.02 mg | EUR 191.42 |
Description: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD-1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. PD-1 is thus one of a growing number of immune checkpoint proteins. |
PD1 Antibody [7H6] |
|||
RF16003-01mg | ProSci | 0.1 mg | EUR 495.22 |
Description: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD-1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. PD-1 is thus one of a growing number of immune checkpoint proteins. |
PD1 Antibody [4C7] |
|||
RF16004-002mg | ProSci | 0.02 mg | EUR 191.42 |
Description: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD-1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. PD-1 is thus one of a growing number of immune checkpoint proteins. |
PD1 Antibody [4C7] |
|||
RF16004-01mg | ProSci | 0.1 mg | EUR 495.22 |
Description: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD-1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. PD-1 is thus one of a growing number of immune checkpoint proteins. |